Infectious Diseases Diagnostics Market

Infectious Diseases Diagnostics Market is expected to reach US$ 1503.8 Mn by 2024
According to the latest market report published by Persistence Market Research, titled “Global
Market Study on Infectious Diseases Diagnostics: Increasing Demand for Evidence-Based
Treatment to Boost Demand for Infectious Diagnostic Testing during Forecast Period”. The global
market for infectious diseases diagnostics is estimated to reach US$ 876.6 Mn in 2016 from US$
827.7 Mn in 2015 owing to increasing demand for diagnostic kits caused by rising incidence rate of
infectious diseases.
The global infectious disease diagnostics market is expected to reach US$ 1503.8 Mn by 2024.
Sexually Transmitted Diseases (STDs) segment is expected to continue to remain the largest
segment by diseases indication accounting for US$ 282.4 Mn in terms of revenue in 2016, a Y – o –
Y increase of 7.0% over 2015. The chlamydia diagnostics test kits are expected to gain upward
momentum in 2016, growing at 8.9% in terms of revenue, the fastest among disease indication
Request to view table of content @
Cell cultures segment is expected to register highest CAGR in terms of revenue, by test type
accounting for US$ 311.4 Mn in terms of revenue in 2016. The affordability of cell culture kits and
large applications in diagnosis of several infectious diseases is gaining traction. Consumption
demand for cell culture test kits will witness a growth rate of 7.2 % in 2016 over 2015.
Diagnostic centers end user segment is expected to register highest CAGR in terms of revenue,
accounting for US$ 392.8 Mn in terms of revenue in 2016. The increasing number of diagnostics
centers, worldwide and a large number of patient pool depending on diagnostics centers for
diagnosis of infectious diseases is expected to increase demand for diagnostics tests among
diagnostics centers. The diagnostics centers end user segment will witness a growth rate of 7.4 % in
2016 over 2015.
Request Sample [email protected]
Becton, Dickinson and Company, Cepheid, Inc. Abbott Laboratories, bioMérieux SA, Hologic, Inc.,
Danaher Corporation, Thermo Fisher Scientific Inc., Roche Diagnostics, Alere Inc., DiaSorin
S.p.A., Quidel Corporation, and Bio-Rad Laboratories, Inc. are key players in the market. Top
players are focusing on developing new products and improving sensitivity and specificity of the
test kits. Collaborations and joint ventures among manufacturers and local governments are key
business strategies being adopted to increase market share.
PMR Long-term Outlook: PMR projects the global infectious disease diagnostics market to witness
moderate growth during the forecast period 2016–2024. APAC will continue to remain the largest
market for infectious disease diagnostics, registering a CAGR of 7.9% over the forecast period
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a
unique collaboration of data analytics and market research methodology to help businesses achieve
optimal performance.To support companies in overcoming complex business challenges, we follow
a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional
sources. By deploying real-time data collection, big data, and customer experience analytics, we
deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: [email protected]